Identification and Verification of Immune Subtype-Related lncRNAs in Clear Cell Renal Cell Carcinoma

BACKGROUND: According to clinical study results, immune checkpoint blockade (ICB) treatment enhances the survival outcome of patients with clear cell renal cell carcinoma (ccRCC). Previous research has divided ccRCC patients into immune subtypes with distinct ICB response rates. However, the study o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhifeng, Chen, Zihao, Guo, Tengyun, Hou, Menglin, Wang, Junpeng, Guo, Yanping, Du, Tao, Zhang, Xiaoli, Wang, Ning, Ding, Degang, Li, Xiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200973/
https://www.ncbi.nlm.nih.gov/pubmed/35719925
http://dx.doi.org/10.3389/fonc.2022.888502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200973/
https://www.ncbi.nlm.nih.gov/pubmed/35719925
http://dx.doi.org/10.3389/fonc.2022.888502

Ejemplares similares